Dr Tsigabu Seyoum, PHARMD | |
Hwy 169 Mm 29, Alamo, NM 87825 | |
(575) 854-2610 | |
Not Available |
Full Name | Dr Tsigabu Seyoum |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | Hwy 169 Mm 29, Alamo, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942859210 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RP00008900 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Tsigabu Seyoum, PHARMD Po Box 5104, Alamo, NM 87825-5104 Ph: (575) 854-2610 | Dr Tsigabu Seyoum, PHARMD Hwy 169 Mm 29, Alamo, NM 87825 Ph: (575) 854-2610 |
News Archive
Older people who have higher blood pressure may have more signs of brain disease, specifically brain lesions, according to a study published in the July 11, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's Disease.
Elevated levels of C-reactive protein, a marker of inflammatory disease, appear to be associated with increased risk of psychological distress and depression in the general population of adults in Denmark, according to a report published Online First by Archives of General Psychiatry, a JAMA Network publication.
Abbott today announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new PLEX-ID Biopreparedness Evaluation Program, which involves Abbott, the Association of Public Health Laboratories and five state public health labs.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
› Verified 6 days ago
Dr. Tsehaye K Zemenfes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Mm 29 Of Highway 169, Alamo, NM 87825 Phone: 575-854-2610 Fax: 575-854-2528 | |
Kibrom Mahray Woress, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Hwy 169 Mm 29, Alamo, NM 87825 Phone: 571-275-3064 |